Evidence map›Paper›PMID 24499609›Full record

Trial reportAddiction science & clinical practice2013

Screening, brief intervention, and referral to treatment (SBIRT) for offenders: protocol for a pragmatic randomized trial.

Michael L Prendergast, Jerome J Cartier

Registry-linked trialOpen access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Addiction science & clinical practice, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01683643 (Screening, Brief Intervention, and Referral to Treatment for Offenders), which is not on this map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01683643 nacompletednot on this map

Screening, Brief Intervention, and Referral to Treatment for Offenders

TypeinterventionalSponsorUniversity of California, Los AngelesRan2012 to 2017Enrolled800ConditionsSubstance Use, HIV InfectionsArmsSBIRT, Control Group
3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 18 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Michael L PrendergastIntegrated Substance Abuse Programs, Semel Institute, David Geffen School of Medicine, University of California, 11075 Santa Monica Blvd,, Suite 100, Los Angeles, CA 90025, USA. mprendergast@mednet.ucla.edu.
Jerome J Cartier
OASIS Clinic · USUniversity of California, Los Angeles · US

Funding

STATISTICAL SUPPORT/DATA MANAGEMENT COREP30DA016383 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI HSER, YIH-ING · 2005 to 2015
$8.6M
Screening, Brief Intervention, and Referral to Treatment (SBIRT) with OffendersR01DA031879 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI PRENDERGAST, MICHAEL LAURENT · 2012 to 2015
$1.5M
NIDA NIH HHS P30 DA016383NIDA NIH HHS R01DA031879
6 · The paper itself

Abstract

backgroundAlthough screening, brief intervention, and referral to treatment (SBIRT) is an evidence-based technique that, in some health-care settings, has been shown to cost-effectively reduce alcohol and drug use, research on the efficacy of SBIRT among criminal offender populations is limited. Such populations have a high prevalence of drug and alcohol use but limited access to intervention, and many are at risk for post-release relapse and recidivism. Thus, there exists a need for treatment options for drug-involved offenders of varying risk levels to reduce risky behaviors or enter treatment. METHODS/

designThis protocol describes an assessment of SBIRT feasibility and effectiveness in a criminal justice environment. Eight-hundred persons will be recruited from a large metropolitan jail, with the experimental group receiving an intervention depending on risk level and the control group receiving minimal intervention. The intervention will assess the risk level for drug and alcohol misuse by inmates, providing those at low or medium risk a brief intervention in the jail and referring those at high risk to community treatment following release. In addition, a brief treatment (eight-session) option will be available. Using data from a 12-month follow-up interview, the primary study outcomes are a reduction in drug and alcohol use, while secondary outcomes include participation in treatment, rearrest, quality of life, reduction in HIV risk behaviors, and costs of SBIRT. EXPECTED VALUE: Individual reductions in alcohol and drug use can have significant effects on public health and safety when observed over a large population at risk for substance-use problems. With wider dissemination statewide or nationwide, a relatively low-cost intervention such as SBIRT could offer demonstrated benefits in this population.

trial registrationClinical Trials Government Identifier, NCT01683643.

Indexed as

Clinical ProtocolsCriminalsAlcoholismFemaleHIV InfectionsHumansLos AngelesMaleMass ScreeningPatient Acceptance of Health CarePersonnel SelectionQuality of LifeResearch DesignRisk AssessmentRisk-TakingSubstance-Related Disorders

Identifiers

PMID24499609
PMCPMC3829109
OpenAlexW2125075406

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.